Azelaic Acid on Demodex Counts in Rosacea

Exclusion Criteria

• •Use of topical therapy for rosacea or other skin conditions on the face within two weeks of Baseline.
• •Use of oral medications for the treatment of rosacea that have been started or altered within the past three months.
• •Presence of a concurrent medical condition or skin condition, which is determined by the investigator to potentially interfere with study outcomes or patient assessments.
• •Subjects with known allergy or sensitivity to azelaic acid gel or components therein, such as propylene glycol.
• •Subjects with known allergy or sensitivity to cyanoacrylates or formaldehyde.
• •Presence of more than two nodules.
• •Female subjects who are not postmenopausal for at least 1 year, surgically sterile or willing to practice effective contraception during the study. Reliable methods of birth control are: abstinence, oral contraceptives, intrauterine device, DepoProvera, tubal ligation or vasectomy of the partner in a monogamous relationship. An acceptable, though less reliable, method involves the careful use of condoms and spermicidal foam or gel and/or a cervical cap or sponge. Nursing mothers, pregnant women and women planning to become pregnant while on study are to be excluded.